Introduction {#Sec1}
============

Epilepsy is a chronic neurologic disorder characterized by repeated epileptic seizures attacks which result from paroxysmal uncontrolled discharges of neurons within the central nervous system^[@CR1]--[@CR4]^. The definition of epilepsy requires the occurrence of at least one epileptic seizure^[@CR3]^. Epilepsy is a major public health problem that affects more than 50 million people worldwide, of whom, 80% were living in developing countries^[@CR5]--[@CR8]^. African countries are among the highly affected regions and it is estimated that ten million people live with epilepsy in Africa^[@CR7],[@CR8]^. Likewise, Ethiopia is affected by epilepsy with a reported prevalence of 5.2/1000 population and annual incidence of 64 per 100,000 population^[@CR9],[@CR10]^.

Antiepileptic Drugs (AEDs) can be indicated for Patients who have had one or more epileptic seizures. The choice of therapy for the management of epilepsy varies depending on the type, frequency, and severity of the seizures^[@CR4],[@CR11]^. Making an accurate diagnosis of the type of epilepsy is crucial to select the best therapy^[@CR8],[@CR11]^. Majority of epileptic seizures are controlled with the optimal use of the currently available AEDs. However, about one-third remained uncontrolled despite optimal therapy^[@CR12],[@CR13]^. Although most of the people with epilepsy can become seizure-free with the optimal use of drug therapy, the treatment outcome in the majority of epileptic patients remains unsatisfactory in resources limited countries^[@CR8]^. Studies have shown that majority \[80--90%\] of the patients with epilepsy are not receiving appropriate treatment in developing countries^[@CR8],[@CR14]^.

A number of problems affect the provision of adequate treatment of epilepsy and these problems are more pronounced in developing countries. The major problems include; lack of qualified medical personnel, unavailability of medications, poor community knowledge and awareness, cultural beliefs, stigma, poor economy, lack of prioritization, and poor health system infrastructure^[@CR14]--[@CR16]^. Many studies have shown that inappropriate drug therapy and non-adherence were the leading causes of poor seizure control^[@CR17]--[@CR19]^.

Several factors have been found to be associated with treatment outcome in epilepsy. These include; gender, age of seizure onset, type of epilepsy, seizure frequency, etiology of epilepsy, duration of epilepsy, electroencephalography abnormality and presence of comorbidities^[@CR14],[@CR20]--[@CR22]^. Poorly controlled seizure leads to impairment of quality of life, excessive bodily injury, neuropsychological impairment, social stigma, reduced marriage rates, poor education, reduced employment levels, and finally shortened lifespan^[@CR23]--[@CR25]^.

Assessment of epileptic patient's treatment outcome and its predictors is crucial to develop treatment optimization strategies and responsible care of patients as clinicians may have difficulty in identifying patients that are less likely to have controlled seizure. Although different studies have been conducted in different parts of the world, there is no adequate data on epilepsy treatment outcome and associated factors in Ethiopia. To our knowledge, there is no study in our particular setting. Hence, our study investigated the treatment outcome and associated factors among epileptic patients.

Methods {#Sec2}
=======

Study design, study setting and study period {#Sec3}
--------------------------------------------

A hospital-based cross-sectional study was conducted from March 2017 to May 2017 at the neurologic clinic of Ayder comprehensive specialized hospital (ACSH), which is the second largest public hospital in Ethiopia with a catchment population of about 10 million people. The study period was from March 2016 to May 2017.

Study participants {#Sec4}
------------------

Adult patients (age ≥ 18 years) with the diagnosis of epilepsy who have been on regular follow- up for at least one year with at least one AED were included in the study. Patients were recruited into the study during their appointment for medication refilling. Patients were excluded if they had a follow-up period of less than one year, seriously ill to complete the interview, refused to give consent, and those with incomplete medical records. A total of 270 patients were included in the study using simple random sampling technique.

Data collection instrument and procedure {#Sec5}
----------------------------------------

All consented epileptic patients who visited the hospital during the data collection period and fulfilled the inclusion criteria were included in the study. Data regarding sociodemographic, medication adherence, medication belief and experience were retrieved by interviewing patients using the standardized questionnaire. Respective medical and medication records were retrieved by reviewing patient's medical record chart using data abstraction checklist. The clinical information of the patients during the last one year follow up period (starting from the date of interview during the data collection period until the last one year) were assessed. All patient were followed for one year to determine their clinical and treatment related characteristics We trained the data collectors about the objective of the study, methods of data collection including data extraction from patient charts as well as techniques of interviewing patients.

Patients' belief about their medication was assessed using the belief about medicines questionnaire (BMQ), which has been validated for use in deferent chronic illness group studies^[@CR26],[@CR27]^. It is a self-reported questionnaire that contains two five-item scales assessing patients' belief about the necessity of the prescribed medications for controlling their illness and their concerns about the potential adverse consequences of taking it. Accordingly, participants were considered to have strong medication necessity belief if the average sum of the five-item medication necessity scale score (ranging from 5--25) is above the midpoint. Conversely, if the score is below this point they were considered to have low medication necessity belief. Similarly, participants were considered to have strong concern belief about their medication adverse effect if the average sum of the five-item medication concern scale score (ranges from 5--25) is above the midpoint, otherwise, they were considered to have low medication concern belief. The overall patients' belief about their medication is obtained by subtracting the average 5--item medication concerns scale score from the average sum of 5--item patient's medication necessity scale score. If the difference is positive, the patient is said to have positive medication belief. Conversely, if it is negative, the patient is said to have negative medication belief.

Medication adherence was assessed using Morisky's medication adherence scale, which has been validated for use in chronic illness adherence assessment^[@CR28]^. It is a self-reported questionnaire which contains eight adherence related questions, in which the total score ranges from 0 to 8 points. The degree of adherence was determined according to the score resulting from the sum of all items. Accordingly, medication adherence was considered as low, medium, and high if the total score is \<6, 6 to \<8, and 8 points, respectively.

Epileptic patients were defined and identified according to the international league against Epilepsy (ILAE)^[@CR3]^. Accordingly, the definition of epilepsy requires the occurrence of at least one epileptic seizure. Participants who had any chronic disease other than epilepsy were considered to have comorbidity. Epileptic patients were said to have psychiatric disorder comorbidity if they had confirmed diagnosis of psychiatric disorders such as depression, schizophrenia, mood disorders, and anxiety by psychiatrist according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5)^[@CR29]^.

Treatment outcome was measured in terms of seizure control status and seizure frequency. In order to evaluate epilepsy treatment outcome, seizure status of the patients in the last one-year follow-up period was considered. Every patient was followed for one year to determine the frequency of seizure in the one-year follow-up period. Operationally, the seizure status was considered to be controlled if the patient had not experienced any seizure attacks in the last one year, and not controlled if the patient experienced one or more seizure attacks in the last one year follow up period.

Data analysis {#Sec6}
-------------

Data were recorded into an EPI data management (version 4.2.0) and analyzed using the Statistical Package for the Social Science (SPSS version 21.0). Descriptive analysis was computed using frequency and mean (standard deviation, SD) for categorical and continuous variables, respectively. The frequency of seizure control status was determined. Multicollinearity was checked to test correlation among predictor variables using variance inflation factor (VIF) and none was collinear. A VIF \< 8 was considered as a cut point for excluding collinearity. Independent variables with p \< 0.2 in univariable binary logistic regression analysis were re-entered into a multivariable binary logistic regression model to identify predictors of treatment outcome in epilepsy. A p value of \< 0.05 was considered statistically significant in all analyses.

Ethical approval and informed consent {#Sec7}
-------------------------------------

This study was approved by the institutional review board (IRB) of Mekelle University, College of Health Sciences. The aim and protocol of the study were fully explained to all patients included in the study and written informed consent was obtained from all participants. The privacy of individual information was strictly preserved. All the methods were performed in accordance with approved institutional guidelines.

Results {#Sec8}
=======

Sociodemographic characteristics of the study participants {#Sec9}
----------------------------------------------------------

A total of 270 epileptic patients were included in this study and analyzed. Of whom, 62% were males and the mean (±SD) age was 30.31 ± 10.95 years. Majorities of the participants were unemployed (73%) and urban dwellers (60%). A large proportion of the participants attended primary and secondary school (30.7% and 51.9%, respectively). With regard to social drug use, 6.3%, 4.1%, and 4.4% of the participants were using alcohol, khat, and cigarette, respectively (Table [1](#Tab1){ref-type="table"}).Table 1Socio--demographic characteristics of the participants (n = 270).CharacteristicsNumber (%)Gender, male168(62)Age in years   18--30163(60.4)   31--6099(36.6)   \>608 (3)Residence, urban162(60)Educational level   Illiterate29 (10.7)   Primary education83(30.7)   Secondary education140(51.9)   College and above18(6.7)Marital status   Married70(25.9)   Single162(60)   Divorced24(8.9)   Widowed14(5.2)Employment status   Employed73(27)   Unemployed197(73)Social drug use   Abstain230(85.2)   Alcohol17(6.3)   khat11(4.1)   Cigarette12(4.4)Monthly income (in Ethiopian Birr)   \<=1500 birr141(52.2)   \>=1500 birr129(47.8)Age at the time of first seizure   \<=1577(28.5)   16--30108(40)   31--4561(22.6)   46--6021(7.8)   \>603(1.1)

Medication belief and adherence status of the participants {#Sec10}
----------------------------------------------------------

Our study reported that majority (70%) of the participants had strong necessity belief towards the importance of their medication while 35% had strong concern belief. Overall, 70% had a positive belief about their medication. More than half (51.5%) of the patients had low adherence to their prescribed medications (Table [2](#Tab2){ref-type="table"}).Table 2Medication belief and adherence status of the participants (n = 270)CharacteristicsNumber (%)Medication necessity belief   Strong necessity belief189(70)   Low necessity belief81(30)Medication concern belief   Strong concern belief94(35)   Low concern belief176(65)Overall medication belief   Negative belief81(30)   positive belief189(70)Level of medication adherence   High adherence27(10)   Medium adherence104(38.5)   Low adherence139(51.5)

Disease and treatment related characteristics {#Sec11}
---------------------------------------------

The mean (±SD) duration of epilepsy was 5.42 ± 3.08 years and the median (IQR) was 5(3--7) years with a range from 1 to 20 years. More than half (59.6%) of the participants had lived with epilepsy for five or more years and 37.8% had one or more comorbidities. The most commonly identified comorbidity among epileptic patients was psychiatric disorder (20.4%). Generalized tonic-clonic seizure (GTCS), 84.4% was the most commonly diagnosed type of epilepsy. Nearly half (48.5%) of the study participants were on monotherapy of AEDs. Our finding reported that 43% of the patients complained about adverse drug events (ADEs) related to their medication (Table [3](#Tab3){ref-type="table"}).Table 3Clinical and treatment related characteristics of the participants (n = 270).CharacteristicsNumber (%)Presence of comorbidity   No102(37.8)   Yes168(62.2)Commonly identified co morbidities   Psychiatric disorder55(20.37)   Migraine headache20(7.4)   Hypertension15(6)   Human immune deficiency virus (HIV)11(4)   Others16(6)Duration of epilepsy in years   Mean ± SD5.42 ± 3.08   Median (IQR)5(3--7)   \<5109(40.4)   ≥5161(59.6)Type of seizure   GTCS220(81.5)   Focal seizure36(13.3)   Absence seizure5(1.9)   Unclassified seizure9(3.3)Number of AED(s)   One131(48.5)   Two125(46.3)   Three14(5.2)ADE   Yes117(43.3)   No153(56.7)GTCS, General tonic-clonic seizure, AED, Anti-epileptic drug, ADE, Adverse drug event, SD, standard deviation, IQR, interquartile range.

Seizure frequency and treatment outcome {#Sec12}
---------------------------------------

Out of the total, 46.6% participants had controlled seizure. Whereas, 38.5%, 8.8%, 5.9% had experienced seizure attacks 1--5 times, 6--10 times, and greater than 10 times, respectively (Table [4](#Tab4){ref-type="table"}).Table 4Distribution of seizure frequency and seizure status of the participants (n = 270).Frequency of seizure during the last one yearNumber (%)**0**126(46.6)1--5 times104(38.5)6--10 times24(8.8)\>10 times16(5.9)

Factors associated with treatment outcome {#Sec13}
-----------------------------------------

Using univariable binary logistic regression analysis, epileptic patients with controlled seizure and uncontrolled were compared using the socio-demographic, disease and medication related characteristics. Accordingly, alcohol consumption \[Crude odds ratio (COR): 4.51, 95% confidence interval (CI): 1.26--16.11\], negative medication belief \[COR: 3.28, 95%CI: 1.86--5.79\], low medication adherence \[COR: 16.69, 95%CI: 5.82--47.87\], presence of comorbidities \[COR: 3.54, 95%CI: 1.47--8.44\], triple AED therapy \[COR: 3.54, 95%CI: 1.47--8.44\], and ADE \[COR: 3.58, 95%CI: 2.16--5.95\] were significantly associated with uncontrolled seizure (Table [5](#Tab5){ref-type="table"}).Table 5Univariable logistic regression analysis of factors associated with treatment outcome of epileptic patients (n = 270).VariablesTreatment outcomeCOR (95% CI)p-valueControlled seizure, n (%)Uncontrolled seizure, n (%)Gender, female42(15.5)60(22.2)1.43(0.87--2.35)0.160Age category18--3070(26)93(34)1131--6051(19)48(18)0.71(0.43--1.17)0.178\>605(2)3(1)0.45(0.10--1.95)0.287Age at seizure onset\<=1533(12.2)44(16.3)1116--3050(18.5)58(21.5)0.87(0.48--1.57)0.64331--4530(11.1)31(11.5)0.78(0.40--1.52)0.459\>4513(4.8)11(4.1)0.64(0.25--1.59)0.333Residence, urban75(27.8)87(32.2)1.04(0.637--1.69)0.881Marital statusMarried70(26)92(34)11Single37(13.7)33(12.2)1.47(0.84--2.59)0.177Divorce10(3.7)14(5.2)1.57(0.62--4.01)0.346Widowed9(3.3)5(2)0.62(0.19--2.05)0.435EducationIlliterate13(4.8)16(5.9)1.54(0.47--5.02)0.475Primary38(14.1)45(16.7)1.48(0.53--4.13)0.453Secondary65(24.1)75(27.8)1.44(0.54--3.87)0.467Tertiary10(3.7%)8(3)11Employment statusUnemployed92(34.1)105(38.9)0.99(0.58--1.70)0.985Employed34(12.6)39(14.4)11Income (in Ethiopian birr)=\<150062(23.0)79(29.3)1.26(0.78--2.03)0.354\>150064(23.7)65(24.1)11Duration of epilepsy\<5 year48(17.8)61(22.6)1.19(0.73--1.95)0.476≥5 year78(28.9)83(30.7)11Alcohol useNo123(45.6)130(48.1)11Yes3(1)14(5.2)4.51(1.26--16.11)0.020SmokingNo120(44.4)139(51.5)11Yes6(2.2)5(2)0.81(0.24--2.71)0.726Khat chewingNo122(45.2)136(50.4)11Yes4(1.5)8(3)1.93(0.57--6.59)0.293Medication beliefPositive belief104(38.5)85(31.5)11Negative belief22(8.2)59(21.9)3.28(1.86--5.79)\<0.001Medication adherenceHigh adherence22(8.2)5(2)11Medium adherence75(27.8)29(10.7)1.70(0.59--4.92)0.326Low adherence29(10.7)110(40.7)16.69(5.82--47.87)\<0.001Co--morbidityNo115(42.6)53(19.6)11Yes11(4.1)91(33.7)17.950(8.87--36.34)\<0.001Type of seizureGTCS101(37.4)119(44.1)11Focal seizure18(6.7)18(6.7)0.85(0.42--1.72)0.648Absence seizure2(0.7)3(1)1.27(0.21--7.760.794Unclassified seizure5(1.9)4(1.5)0.68(0.18--2.60)0.572Number of AEDsOne68(25.2)60(22.2)11Two50(18.5)59(21.9)1.34(0.80--2.23)0.266Three8(3)25(9.3)3.54(1.47--8.44)0.004ADENo73(27)40(14.8)11Yes53(19.6)104(38.5)3.58(2.16--5.95)\<0.001COD, Crude odds ratio, CI, Confidence interval, AED, antiepileptic drugs, ADE, adverse drug event, GTCS, Generalized tonic-clonic seizure.

On further multivariable binary logistic regression model; Alcohol consumption \[adjusted odd ratio (AOR): 14.87, 95% CI: 3.25--68.11\], negative medication belief \[AOR: 3.0, 95%CI: 1.31--6.71\], low medication adherence \[AOR: 11.52, 95%CI:3.25--40.82\], and presence of comorbidities \[AOR: 10.346, 95%CI: 4.387--24.399\] were found to be predictors of uncontrolled seizure (Table [6](#Tab6){ref-type="table"}).Table 6Multivariable logistic regression analysis of factors associated with treatment outcome among epileptic patients (n = 270).PredictorsTreatment out comeAOR (95%CI)p-valueControlled seizure, n (%)Uncontrolled seizure, n (%)Gender, female42(16)60(21.9)1.78(0.87--3.71)0.114Age category18--3070(26)93(34)1131--6051(19)48(18)0.79(0.22--2.92)0.726\>605(2)3(1)1.79(0.05--62.2)0.749Marital statusMarried70(26)92(34)11Single37(13.7)33(12.2)1.55(0.40--6.08)0.526Divorce10(3.7)14(5.2)1.24(0.31--5.01)0.761Widowed9(3.3)5(2)0.73(0.05--9.74)0.808Alcohol useNo123(45.6)130(48.1)11Yes3(1)14(5.2)14.87(3.25--68.1)\<0.001Medication beliefPositive belief104(38.585(31.5)11Negative belief22(8.2)59(21.9)3.00(1.301--6.71)0.009Medication adherenceHigh adherence22(8.2)5(2)11Medium adherence75(27.8)29(10.7)2.46(0.70--8.77)0.166Low adherence29(10.7)110(40.7)11.52(3.25--40.82)\<0.001ComorbidityNo115(42.6)53(19.6)11Yes11(4.1)91(33.7)10.35(4.40--24.40)\<0.001Number of AEDsOne68(25.2)60(22.2)11Two50(18.5)59(21.9)1.09(0.51--2.32)0.819Three8(3)25(9.3)1.84(0.57--5.96)0.310ADENo73(27)40(14.8)11Yes53(19.6)104(38.5)2.132(0.891--5.102)0.089AOD, Adjusted odds ratio, CI, Confidence interval, AED, antiepileptic drugs, ADE, adverse drug event.

Discussion {#Sec14}
==========

Currently, therapeutic advances have resulted in meaningful changes in the diagnosis and management of epilepsy^[@CR30]^. However, the practice of epilepsy management is inconsistent in different countries depending on the available expertise and resource^[@CR8]^. Although evidence has shown that a greater proportion of epileptic patients become seizure free with the optimal use of the available AEDs^[@CR8],[@CR11]--[@CR13]^, less than half of the patients remain seizure free in our study. This could be attributed to the lack of qualified medical personnel, unavailability of medications, poor community knowledge and awareness, and poor health system infrastructure in our setting where resources are limited. Our finding is also quite different from a study done in Gonder, Ethiopia^[@CR31]^ in which 82% of the epileptic patients achieve seizure remission over 3 months follow-up period. This variation could be due to the difference in follow-up period (3 months vs. 12 months). In line with our study, the majority of the patients had uncontrolled seizure in other similar studies^[@CR32]--[@CR34]^.

Several studies revealed that alcohol consumption is a risk factor for developing seizure and it increased the risk of seizure in epileptic patients^[@CR35]--[@CR38]^. Similarly, alcohol was found to be a predictor of uncontrolled seizure in our study. This could be explained that alcohol consumption could lead to sleep deprivation, missing meals, missing medications and increase the side effect of AED which were reported as triggering factors of seizure^[@CR14],[@CR35]--[@CR38]^. Hence, much should be done on awareness of alcohol use of epileptic patients.

Our finding reported that low medication adherence was significantly associated with uncontrolled seizure. In agreement to our study, many studies have shown that non-adherence to medication was the leading cause poor epilepsy control^[@CR14],[@CR17],[@CR19],[@CR31],[@CR32],[@CR39]^. In addition, our study revealed that patients with a negative medication belief were less likely to have seizure free period compared to those with a positive medication belief. The possible justification for this could be patients with a negative medication belief are less likely to adhere to their medications as revealed by our study and other similar studies^[@CR40],[@CR41]^. Hence, educational programs should be designed to improve the perception of patients about their medication as well as their medication adherence. Our study also reported that epileptic patients with comorbidity were less likely to have controlled seizure than those without comorbidities which is in line other similar studies^[@CR41]--[@CR43]^. Thus, more emphasis should be given to these patients.

Patients with a triple AED therapy and those who experienced ADEs were less likely to have seizure-free period though statistically not significant on the multivariable regression model. Even though evidence-based guidelines recommend the use of monotherapy for the majority of epileptic patients^[@CR41],[@CR44],[@CR45]^, only 48.5% were maintained on monotherapy in our study. Overall, utilization of monotherapy was found to be low compared to other similar studies^[@CR14],[@CR46],[@CR47]^. This could be due to the absence of specific epilepsy treatment guideline and lack of expertise of healthcare professionals in our setup. Our study reported that 43% of the patients had experienced ADE related to their AED therapy. This finding is higher compared to the studies conducted in Gonder (17.6%) and Jimma (33.4%); Ethiopia^[@CR31],[@CR48]^. This could be attributed to the higher use of multiple AED therapy in our setting.

Finally, our study is not without limitations. The cross-sectional nature of the study may not provide adequate evidence of causality regarding seizure control status and its predictors. Due to self-report concerns, patients may understate socially undesirable activities like medication non-adherence and negative medication belief.

Conclusion {#Sec15}
==========

Our findings revealed that more than half of the epileptic patients have uncontrolled seizure. Epileptic patients with a negative medication belief, comorbidities, low medication adherence and those who consume alcohol were more likely to have uncontrolled seizure. Therefore, particular consideration should be given to these potentially modifiable risk factors. Educational programs about the importance of their medication, adherence, and precipitating factors such as alcohol should be given. Moreover, we recommend researchers to do further longitudinal and interventional studies with more strong study design to provide adequate evidence about the cause-effect relationship between the predictor variables and seizure control.
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